SYNLOGIC, INC. Earnings Per Share (Basic)
SYNLOGIC, INC. (SYBX) reported Earnings Per Share (Basic) of -$0.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- SYNLOGIC, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.04.
- SYNLOGIC, INC. earnings per share, basic for the quarter ending 2026-03-31 was $0.05, a 66.67% increase year-over-year.
- SYNLOGIC, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.19.
- SYNLOGIC, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.04, a 116.00% decline year-over-year.
- SYNLOGIC, INC. earnings per share, basic for fiscal 2025 was -$0.08.
- SYNLOGIC, INC. earnings per share, basic for fiscal 2024 was -$1.92.
- SYNLOGIC, INC. earnings per share, basic for fiscal 2023 was -$9.42.
- SYNLOGIC, INC. earnings per share, basic for fiscal 2022 was -$13.83.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.04 10-Q · filed 2026-08-11 | $0.01 10-Q · filed 2026-08-11 | ||||||
| 2026-03-31 | $0.05 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$0.08 10-K · filed 2026-03-12 | |||||||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-13 | -$0.20 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$0.04 10-Q · filed 2026-08-11 | -$0.02 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | $0.03 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$1.92 10-K · filed 2026-03-12 | |||||||
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-13 | -$1.86 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | $0.25 10-Q · filed 2025-08-07 | $0.16 10-Q · filed 2024-08-08 | -$1.85 10-Q · filed 2025-08-07 | -$2.43 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | -$2.11 10-Q · filed 2025-05-08 | -$2.60 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | -$9.42 10-K · filed 2025-03-06 | -$8.81 10-K · filed 2024-03-19 | ||||||
| 2023-09-30 | -$2.57 10-Q · filed 2024-11-12 | -$9.17 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$3.21 10-Q · filed 2024-08-08 | -$0.21 10-Q · filed 2023-08-10 | -$6.61 10-Q · filed 2024-08-08 | -$0.44 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | -$3.39 10-Q · filed 2024-05-14 | -$0.23 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | -$13.83 10-K · filed 2024-03-19 | -$0.92 10-K · filed 2023-03-29 | ||||||
| 2022-09-30 | -$3.73 10-Q · filed 2023-11-09 | -$0.25 10-Q · filed 2022-11-10 | -$10.29 10-Q · filed 2023-11-09 | -$0.69 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | -$0.22 10-Q · filed 2023-08-10 | -$0.44 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$0.22 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$1.09 10-K · filed 2023-03-29 | |||||||
| 2021-09-30 | -$0.29 10-Q · filed 2022-11-10 | -$0.91 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$0.28 10-Q · filed 2022-08-11 | -$0.63 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |